Adam completed a master's degree in Molecular and Cellular Biochemistry at the University of Oxford and joined the Babraham Institute in 2018 as a PhD student, where he studied the key epigenetic regulators involved in human naive pluripotency and reprogramming. After a year working in industry at a biotechnology startup, Adam is now studying the epigenetic regulation of human pre-implantation development, using both pluripotent stem cells and 3D stem cell-based embryo models.